Latest Singulair news
FDA: Montelukast Tablet Bottles Recalled
posted September 4th
by modernClinician Editorial Team
by modernClinician Editorial Team
Some bottles of montelukast (Singulair) tablets for asthma have been recalled by Camber Pharmaceuticals because they contain the wrong medication, the U.S. Food and Drug Administration says.
Montelukast Associated With Nightmares, Depression
posted September 21st
by modernClinician Editorial Team
by modernClinician Editorial Team
Montelukast appears to be linked to neuropsychiatric side effects, such as depression, aggression, nightmares, and headaches, according to a review published online Sept. 20 in Pharmacology Research and Perspectives.
2013 to 2024 Saw Decrease in Benzodiazepine Prescribing 
Childhood Cancer Survivors Often Have Mental Distress in Adulthood 
Study IDs Risk Factors for Ketoacidosis in Adults With T2D Receiving SGLT2 Inhibitors 
Air Pollution Tied to Higher Risk for Suicide 
Insomnia Linked to Increased Risk for Stroke, Odds of Admission 
Age-Adjusted Suicide Rate Increased From 2014 to 2017 and Then Plateaued 
Psychiatrists Only Agree 55 Percent of the Time on Diagnoses 
Youth Suicide Risk Linked to Community Firearm Violence Monthly Specialist Briefings
Stay Connected
